米国の医療診断市場は、2026年に401億ドルに達し、2022年から2026年までのCAGRは4.63％と予想されます。高齢者人口の増加、慢性疾患の負担の増加、電子カルテ（EHR）システムの普及拡大、医療費の増加、都市化の拡大などの要因が市場の成長を後押しします。一方で、熟練した検査技師の不足、ハイエンドの分子診断、高額な体外診断装置のコスト、市販前承認（PMA）およびIVDラベリング要件の難しさなどが成長の課題となります。いくつかの注目すべき動向としては、ウェアラブルなどのヘルスケア関連デバイスの急増、さまざまなパンデミック疾患の出現、人工知能との一体化、個別化医療に対する意識の高まりなどがあります
米国の医療診断市場は、種類別、製品の種類別、エンドユーザー別に分類されています。種類別には体外診断と生体内診断に分類されますます。T米国の体外診断市場は、さらに製品の種類別と用途別に、分類されます。製品の種類別には薬剤、機器、ソフトウェアとサービスに分類されます。一方、エンドユーザー別には、病院、診断センター、Physician Office Labs（POL）などに分類できます。
目次
1. Market Overview
1.1 Introduction
1.2 Types of Diagnostics
1.3 General Components of a Diagnostic Procedure
1.4 Anatomy of a Diagnostic Test
1.5 Categories of Diagnostic Tests
1.6 Major Roles of Diagnostic Testing
1.7 Sources of Medical Information for Diagnosis
1.8 Common Types of Diagnostic Tools
2. Impact of COVID-19
2.1 Demand Surge for Medical Diagnostics
2.2 Growth in Government Spending on Healthcare
2.3 Surging Adoption of Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
3. The U.S. Market Analysis
3.1 The U.S. Medical Diagnostics Market by Value
3.2 The U.S. Medical Diagnostics Market Forecast by Value
3.3 The U.S. Medical Diagnostics Market by Type
3.3.1 The U.S. In-Vitro Diagnostics Market by Value
3.3.2 The U.S. In-Vitro Diagnostics Market Forecast by Value
3.3.3 The U.S. In-Vitro Diagnostics Market by Product Type
3.3.4 The U.S. In-Vitro Diagnostics Product Type Market by Value
3.3.5 The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value
3.3.6 The U.S. In-Vitro Diagnostics Market by Application
3.3.7 The U.S. In-Vitro Diagnostics Application Market Forecast by Value
3.3.8 The U.S. In-Vivo Diagnostics Market by Value
3.3.9 The U.S. In-Vivo Diagnostics Market Forecast by Value
3.4 The U.S. Medical Diagnostics Market by Product Type
3.4.1 The U.S. Medical Diagnostics Product Type Market by Value
3.4.2 The U.S. Medical Diagnostics Product Type Market Forecast by Value
3.5 The U.S. Medical Diagnostics Market by End-Users
3.5.1 The U.S. Medical Diagnostics End-User Market by Value
3.5.2 The U.S. Medical Diagnostics End-User Market Forecast by Value
3.6 The U.S. Medical Diagnostics Market by Region
4. Regional Market Analysis
4.1 Southern U.S.
4.1.1 Southern U.S. Medical Diagnostics Market Forecast by Value
4.2 Mid-Western U.S.
4.2.1 Mid-Western U.S. Medical Diagnostics Market Forecast by Value
4.3 Western U.S.
4.3.1 Western U.S. Medical Diagnostics Market Forecast by Value
4.4 North Eastern U.S.
4.4.1 North Eastern U.S. Medical Diagnostics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Growing Burden of Chronic Diseases?
5.1.3 Escalating Penetration of Electronic Health Record (EHR) Systems
5.1.4 Hike in Healthcare Expenditure
5.1.5 Expanding Urbanization
5.2 Key Trends and Developments
5.2.1 Surging Adoption of Healthcare-related Devices Like Wearables
5.2.2 Emergence of Various Pandemic Diseases
5.2.3 Rising Integration with Artificial Intelligence
5.2.4 Growing Awareness on Personalized Medicine
5.3 Challenges
5.3.1 Dearth of Trained Laboratory Technicians
5.3.2 High Cost of High-end Molecular Diagnostics & In-Vitro Diagnostics Devices
5.3.3 Challenging Premarket Approval (PMA) & IVD Labelling Requirements
6. Competitive Landscape
6.1 The U.S. Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
7. Company Profiles
7.1 Roche Holding AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Danaher Corporation
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Becton, Dickinson and Company
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Quest Diagnostics Inc.
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 BioMerieux SA
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
List of Figures
Process of Medical Diagnosis
Types of Diagnostics
General Components of a Diagnostic Procedure
Categories of Diagnostic Tests
Major Roles of Diagnostic Testing
Sources of Medical Information for Diagnosis
Common Types of Diagnostic Tools
Number of COVID-19 Tests Performed Daily in the U.S. (March - November 2020)
The U.S. National Health Expenditure as Percent of GDP (2016-2020)
Molecular Assays Performed per Week in the U.S. (March-October 2020)
The U.S. Medical Diagnostics Market by Value (2017-2021)
The U.S. Medical Diagnostics Market Forecast by Value (2022-2026)
The U.S. Medical Diagnostics Market by Type (2021)
The U.S. In-Vitro Diagnostics Market by Value (2017-2021)
The U.S. In-Vitro Diagnostics Market Forecast by Value (2022-2026)
The U.S. In-Vitro Diagnostics Market by Product Type (2021)
The U.S. Medical Diagnostics Application Market by Value (2017-2021)
The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value (2022-2026)
The U.S. In-Vitro Diagnostics Market by Application (2021)
The U.S. In-Vitro Diagnostics Application Market Forecast by Value (2021-2026)
The U.S. In-Vivo Diagnostics Market by Value (2017-2021)
The U.S. In-Vivo Diagnostics Market Forecast by Value (2022-2026)
The U.S. Medical Diagnostics Market by Product Type (2021)
The U.S. Medical Diagnostics Product Type Market by Value (2017-2021)
The U.S. Medical Diagnostics Product Type Market Forecast by Value (2022-2026)
The U.S. Medical Diagnostics Market by End-Users (2021)
The U.S. Medical Diagnostics End-User Market by Value (2017-2021)
The U.S. Medical Diagnostics End-User Market Forecast by Value (2022-2026)
The U.S. Medical Diagnostics Market by Region (2021)
Southern U.S. Medical Diagnostics Market Forecast by Value (2021-2026)
Mid-Western U.S. Medical Diagnostics Market Forecast by Value (2021-2026)
Western U.S. Medical Diagnostics Market Forecast by Value (2021-2026)
North Eastern U.S. Medical Diagnostics Market Forecast by Value (2021-2026)
The U.S. Population 65 Years and Older (2015-2060)
Number of People with Chronic Conditions in the U.S. (2010-2030)
Penetration Forecast of Electronic Health Record (EHR) Systems in the U.S.
The U.S. National Healthcare Expenditure Forecast (2016-2024)
Degree of Urbanization in the U.S. (2015-2030)
Number of Wearable Device Users in the U.S. (2017-2022)
Artificial Intelligence in Diagnostics Market in the U.S. (2020-2026)
Roche Holding AG Sales and Net Income (2016-2020)
Roche Holding AG Sales by Segment (2020)
Roche Holding AG Sales by Region (2020)
Abbott Laboratories Net Sales and Net Earnings (2016-2020)
Abbott Laboratories Net Sales by Segment (2020)
Abbott Laboratories Net Sales by Region (2020)
Danaher Corporation Sales and Net Earnings (2017-2021)
Danaher Corporation Sales by Segment (2021)
Becton, Dickinson and Company Revenue and Net Income (2017-2021)
Becton, Dickinson and Company Revenue by Segment (2021)
Becton, Dickinson and Company Revenue by Region (2021)
Quest Diagnostics Inc. Net Revenue and Net Income (2016-2020)
Quest Diagnostics Inc. Net Revenue by Segment (2020)
BioMerieux SA Sales and Net Income (2016-2020)
BioMerieux SA Sales by Segment (2020)
BioMerieux SA Sales by Region (2020)
List of Tables
Anatomy of a Diagnostic Test
Brief History of Pandemics (1918-2020)
Revenue Comparison of Key Players (2020/2021)
Market Capitalization Comparison of Key Players (2022)
R&D Comparison of Key Players (2020/2021)
